Sports nutrition sales steady despite price hike, yogurt sales still down – Meiji

By Tingmin Koe contact

- Last updated on GMT

Sales of the SAVAS series remained largely unchanged, although prices were raised and product volume reduced, said Meiji. ©Meiji
Sales of the SAVAS series remained largely unchanged, although prices were raised and product volume reduced, said Meiji. ©Meiji

Related tags: Meiji, Sports nutrition, Yogurt

Sales of sports nutrition products under the brand SAVAS have remained steady despite price rises and a reduction in product volumes, Meiji has reported in its FY22 Q1 results.

However, sales of functional yogurt continued to decline yoy, largely due to market competition.

According to the firm’s latest financial results, while net sales had increased yoy, operating profit had declined mainly due to high raw material costs and marketing expenses.

Across all product categories, net sales were up 11.2 per cent yoy to JPY$247.1bn (US$1.86bn), driven by growth in the firm’s nutrition business, B2B business, chocolate and gummy business.

Operating profit was down 3.1 per cent to JPY$18 bn (US$135m), while profit attributable to owners was up 28.2 per cent yoy to JPY$16bn (US$120m).

For its nutrition business, which consists of sports, infant, and enteral nutrition, net sales were up 5.8 per cent to JPY$28.9bn (US$216m). Operating profit was down 14.4 per cent to JPY$4.1Bbn (US$30.8m).

In particular, sales of its sports nutrition brand SAVAS had increased 0.6 per cent to JPY$11.8 billion (US$88.6m), with favourable sales from RTD products.   

“Sales of the SAVAS series remained largely unchanged, even though the firm had raised prices and reduced product volume. Sales of the ready-to-drink products were favourable,”​ the company said.

This is against the backdrop of a shrinking sports protein powder and granules market – which had shrunk four to five per cent, said the firm.

On the other hand, the sales of infant formula and enteral formula had increased 11.7 per cent to JPY$16.3 billion (US$122m).

“Sales of liquid diet Meiji Mei Balance and infant formula, in which the firm had caught some inbound demand, were favourable,”​ the firm said.

Meiji Mei Balance is a drink designed for older adults and individuals with a low appetite.  

Functional yogurt sales declined

As compared to the nutrition category, sales from yogurt and functional yogurt had decreased by 2.4 per cent.

In particular, the sales of functional yogurt had decreased 9.8 per cent YoY to JPY$22.8bn (US$171m).

“For functional yogurt and yogurt, we expanded our product line and strengthened marketing activities, but sales decreased due to the impact of various competitor products appealing health value,”​ the company said.

Some products, such as LG21 yogurt and Probio Yogurt R-1 had declined yoy, with the exception of the newly launched Mitasukarada series that was out in April.

The company has been reporting a decline in functional yogurt sales​ in recent months. While sales of its core customers remained stable, it was struggling to attract new customers, it said. 

Revamped products

On August 30, Meiji will be releasing its first labelless yogurt drink bottled products under the Meiji Probio Yogurt R-1 brand.  

Doing so will help reduce the use of plastic and expand the use of environmentally friendly materials.

“Adopting labelless bottles is expected to reduce the amount of plastic used per bottle by approximately 8.5 per cent, contributing to a reduction in environmental impact,” ​the firm said.

The labelless bottles will be sold in boxes of six. 

Related news

Show more

Related products

show more

Broadening formulation with Postbiotic LAC-Shield™

Broadening formulation with Postbiotic LAC-Shield™

Morinaga Milk Industry Co., Ltd. | 25-Nov-2022 | Technical / White Paper

Postbiotic emerges as a strong biotic solution for functional food and drink products, especially those that probiotic bacteria cannot thrive in. LAC-Shield™...

Winclove introduces Ecologic® AAD

Winclove introduces Ecologic® AAD

Winclove Probiotics | 05-Oct-2022 | Product Brochure

Ecologic® AAD has been tested in a randomized, double-blind, placebo-controlled trial with healthy volunteers taking amoxicillin, performed by Maastricht...

eBook: Press reset on joint health with Lonza

eBook: Press reset on joint health with Lonza

Lonza | 20-Sep-2022 | Technical / White Paper

It’s no secret the pandemic had a profound and prolonged effect on the way we live and move. Now, consumers of all ages are looking to press reset on their...

Related suppliers

Follow us

Products

View more

Webinars

Nutra Champions Podcast

Nutra Champions Podcast